X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
aged (7) 7
middle aged (7) 7
adult (6) 6
female (6) 6
hematology (6) 6
male (6) 6
index medicus (5) 5
chemotherapy (4) 4
aged, 80 and over (3) 3
cancer (3) 3
health aspects (3) 3
hematologic neoplasms - drug therapy (3) 3
life sciences (3) 3
medicine & public health (3) 3
retrospective studies (3) 3
risk factors (3) 3
time factors (3) 3
young adult (3) 3
17-aag (2) 2
acute myeloid-leukemia (2) 2
adolescent (2) 2
benzoquinones - pharmacology (2) 2
cancer-patients (2) 2
child (2) 2
confidence intervals (2) 2
epidemiology (2) 2
flow cytometry (2) 2
follow-up studies (2) 2
france (2) 2
hsp90 (2) 2
hsp90 heat-shock proteins - metabolism (2) 2
infections (2) 2
internal medicine (2) 2
lactams, macrocyclic - pharmacology (2) 2
leukemia (2) 2
lymphomas (2) 2
medicine (2) 2
mortality (2) 2
neutropenia (2) 2
odds ratio (2) 2
oncology (2) 2
patients (2) 2
prognosis (2) 2
proportional hazards models (2) 2
prospective studies (2) 2
survival rate (2) 2
17-allylamino-17-demethoxygeldanamycin (1) 1
99m tc--dmsa (1) 1
[ sdv ] life sciences [q-bio] (1) 1
[ sdv.mp.myc ] life sciences [q-bio]/microbiology and parasitology/mycology (1) 1
[sdv.mp.myc]life sciences [q-bio]/microbiology and parasitology/mycology (1) 1
abridged index medicus (1) 1
acute kidney failure (1) 1
acute kidney injury - blood (1) 1
acute kidney injury - chemically induced (1) 1
acute kidney injury - drug therapy (1) 1
acute kidney injury - epidemiology (1) 1
acute kidney injury - therapy (1) 1
acute lung injury - etiology (1) 1
acute lung injury - physiopathology (1) 1
acute lymphoblastic leukaemia (1) 1
acute myeloid leukemia (1) 1
acute respiratory failure (1) 1
acute-lymphoblastic-leukemia (1) 1
acute-renal-failure (1) 1
addition (1) 1
adhäsion (1) 1
adolescents (1) 1
adults (1) 1
aetiological source (1) 1
allo-sct (1) 1
allogeneic transplantation (1) 1
allopurinol - administration & dosage (1) 1
allopurinol - therapeutic use (1) 1
analysis (1) 1
anesthesiology (1) 1
anti-bacterial agents - therapeutic use (1) 1
anti-thymocyte-globulin (1) 1
antibiotics (1) 1
antifungal agents - therapeutic use (1) 1
antifungal prophylaxis (1) 1
antilymphocyte serum - therapeutic use (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antithymocyte globulin (1) 1
antithymoglobulin doses (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
apoptosis - genetics (1) 1
aspergillus-fumigatus (1) 1
autografts (1) 1
autologous transplantation (1) 1
b-lymphocytes - drug effects (1) 1
b-lymphocytes - metabolism (1) 1
bacteremia (1) 1
bam (1) 1
bcl-2-associated x protein - genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CODOX-M/IVAC | CLEAVED-CELL LYMPHOMA | ACUTE-LYMPHOBLASTIC-LEUKEMIA | MULTIAGENT CHEMOTHERAPY | ADOLESCENTS | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | SURVIVAL RATE | PEDIATRIC-ONCOLOGY-SOCIETY | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 11/2017, Volume 43, Issue 11, pp. 1613 - 1625
Microbiological diagnosis (MD) of infections remains insufficient. The resulting empirical antimicrobial therapy leads to multidrug resistance and... 
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Sepsis | Anesthesiology | Aetiological source | Bacteremia | PCR | DIAGNOSIS | COST-EFFECTIVENESS | GUIDELINES | NEUTROPENIC PATIENTS | DE-ESCALATION | DISEASES SOCIETY | SEPTIC SHOCK | BLOOD-STREAM INFECTIONS | EPIDEMIOLOGY | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Endocarditis - blood | Febrile Neutropenia - mortality | Humans | Middle Aged | Sepsis - diagnosis | Intensive Care Units - statistics & numerical data | Male | Molecular Diagnostic Techniques - economics | Time-to-Treatment - economics | Anti-Bacterial Agents - therapeutic use | Endocarditis - diagnosis | Time Factors | Endocarditis - mortality | Female | Retrospective Studies | Febrile Neutropenia - diagnosis | Hospital Mortality | Risk Factors | Sepsis - mortality | Cross-Over Studies | Febrile Neutropenia - blood | Quality Improvement | Cost-Benefit Analysis | Intention to Treat Analysis | Aged | Sepsis - blood | Diagnosis | Health aspects | Endocarditis | Health care | Intervention | Pathogens | Multidrug resistance | Infections | Clustering | Patients | Empirical analysis | Blood | Confidence intervals | Randomization | Multilevel | Clusters | Diagnostic systems | Cost analysis | Neutropenia | Life Sciences | Microbiology and Parasitology | Mycology | Original
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2013, Volume 162, Issue 4, pp. 489 - 497
Summary In tumour lysis syndrome (TLS), metabolic alterations caused by the destruction of malignant cells manifest as laboratory abnormalities with (clinical... 
haemodialysis | acute kidney failure | haematologic malignancy | hyperphosphataemia | intensive care units | Intensive care units | Hyperphosphataemia | Acute kidney failure | Haemodialysis | Haematologic malignancy | BURKITT LYMPHOMA/LEUKEMIA | PREVENTION | ACUTE-RENAL-FAILURE | RECOMBINANT URATE OXIDASE | PREDICTIVE MODEL | ACUTE MYELOID-LEUKEMIA | CHEMOTHERAPY | CANCER-PATIENTS | HYPERURICEMIA | HEMATOLOGY | CRITICALLY-ILL PATIENTS | Fluid Therapy | Urate Oxidase - therapeutic use | Prevalence | Prospective Studies | Hematologic Neoplasms - mortality | Humans | Middle Aged | Tumor Lysis Syndrome - blood | Male | Renal Replacement Therapy - utilization | Tumor Lysis Syndrome - etiology | Tumor Lysis Syndrome - epidemiology | Adult | Female | Acute Kidney Injury - chemically induced | Hematologic Neoplasms - complications | Drug Therapy, Combination | Urate Oxidase - administration & dosage | Acute Kidney Injury - drug therapy | Comorbidity | Acute Kidney Injury - blood | Risk Factors | Proportional Hazards Models | Tumor Burden | Remission Induction | Disease-Free Survival | Allopurinol - therapeutic use | Bicarbonates - administration & dosage | Allopurinol - administration & dosage | Hyperphosphatemia - etiology | Biomarkers | Hematologic Neoplasms - drug therapy | Hyperphosphatemia - drug therapy | Acute Kidney Injury - therapy | Aged | Tumor Lysis Syndrome - drug therapy | Acute Kidney Injury - epidemiology
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 10/2012, Volume 138, Issue 10, pp. 1753 - 1758
Journal Article
Journal Article
Acta Haematologica, ISSN 0001-5792, 11/2016, Volume 136, Issue 4, pp. I - IV
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.